Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2014
09/18/2014US20140271866 Transdermal drug delivery system containing rivastigmine
09/18/2014US20140271865 Amphetamine transdermal compositions with acrylic block copolymer
09/18/2014US20140271864 Therapeutic compositions for bone repair
09/18/2014US20140271863 Hot washable poly-n-isopropylacrylamide hydrogel delivery systems
09/18/2014US20140271862 Rapid Disperse Dosage Form Containing Levetiracetam
09/18/2014US20140271861 Matrix compositions for controlled release of peptide and polypeptide molecules
09/18/2014US20140271859 Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
09/18/2014US20140271858 Coated tablets of eszopiclone
09/18/2014US20140271857 Benzonatate modified release solid tablets and capsules
09/18/2014US20140271856 Orally disintegrable tablets
09/18/2014US20140271855 Sovaprevir tablets
09/18/2014US20140271852 Sustained release formulation of nalbuphine
09/18/2014US20140271851 Antiemetic extended release solid dosage forms
09/18/2014US20140271850 Controlled-Release Pharmaceutical Compositions Comprising Lamotrigine and Methods of Producing Same
09/18/2014US20140271849 Abuse Deterrent Solid Dosage Form for Immediate Release with Functional Score
09/18/2014US20140271848 Abuse-deterrent dosage forms
09/18/2014US20140271847 Formulations and methods for rapid penile erections
09/18/2014US20140271846 Gastroretentive dosage system and process of preparation thereof
09/18/2014US20140271845 Coated substrate compositions
09/18/2014US20140271843 Multi-Layer Hydrogel Capsules for Encapsulation of Cells and Cell Aggregates
09/18/2014US20140271839 Extended-release topiramate capsules
09/18/2014US20140271838 Pharmaceutical soft gelatin capsule dosage form with modified guar gum
09/18/2014US20140271837 Pharmaceutical soft gelatin capsule dosage form
09/18/2014US20140271836 Manufacture of peanut formulations for oral desensitization
09/18/2014US20140271835 Abuse resistant capsule
09/18/2014US20140271834 Doxycycline Formulations, and Methods of Treating Rosacea
09/18/2014US20140271833 Injection-molded dosage form
09/18/2014US20140271832 Racecadotril lipid compositions
09/18/2014US20140271827 Lipid vesicle compositions and methods of use
09/18/2014US20140271826 Kinetin/zeatin topical formulation
09/18/2014US20140271825 Pharmaceutical formulations of chelating agents as a metal removal treatment system
09/18/2014US20140271824 Acid Stable Liposomal Compositions And Methods For Producing The Same
09/18/2014US20140271822 Modified docetaxel liposome formulations
09/18/2014US20140271821 Liposomal cisplatin compositions for cancer therapy
09/18/2014US20140271820 Liposome oxaliplatin compositions for cancer therapy
09/18/2014US20140271816 Treatment of potential platelet aggregation with liposomally formulated glutathione and clopidogrel
09/18/2014US20140271815 Heat-and freeze-stable vaccines and methods of making and using same
09/18/2014US20140271814 Cell binding peptide drug delivery system and compound for treating cancer and tumors
09/18/2014US20140271813 Liposome formulation and manufacture
09/18/2014US20140271811 Topical systems and methods for treating sexual dysfunction
09/18/2014US20140271810 Hair treatment systems and methods using peptides and other compositions
09/18/2014US20140271808 Systems and methods for delivery of peptides
09/18/2014US20140271805 Compositions and methods for affecting mood states
09/18/2014US20140271804 Methods and systems for treating or preventing cancer
09/18/2014US20140271803 Peptide systems and methods for metabolic conditions
09/18/2014US20140271802 Wound healing using topical systems and methods
09/18/2014US20140271801 Cardiovascular disease treatment and prevention
09/18/2014US20140271800 Immune modulation using peptides and other compositions
09/18/2014US20140271799 Transdermal administration of fentanyl and analogs thereof
09/18/2014US20140271798 Topical Copper Ion Treatments and Methods of Making Topical Copper Ion Treatments for Use in Various Anatomical Areas of the Body
09/18/2014US20140271796 Oxybutynin-containing transdermal absorption preparation
09/18/2014US20140271795 Nanofibrous materials as drug, protein, or genetic release vehicles
09/18/2014US20140271792 Methylphenidate transdermal compositions with rubber-based adhesives
09/18/2014US20140271790 Fascia fibrous compositions and methods for their use and manufacture
09/18/2014US20140271789 Sublingual and buccal film compositions
09/18/2014US20140271788 Sublingual and buccal film compositions
09/18/2014US20140271787 Continuous single layer film structure including discrete domains
09/18/2014US20140271783 Prefabricated pharmaceutical dosage forms from functional polymer films
09/18/2014US20140271782 Method for preparing nanolipids with encapsulated alcohol
09/18/2014US20140271781 Hydrogel compositions with an erodible backing member
09/18/2014US20140271780 Prostamide-containing intraocular implant
09/18/2014US20140271778 Encapsulated kidney tissue
09/18/2014US20140271772 Biodegradable subcutaneous implants and methods of making
09/18/2014US20140271767 Biocompatible hydrogel polymer matrix for delivery of cells
09/18/2014US20140271766 Methods and device for treating opioid addiction
09/18/2014US20140271765 Methods and device for treating opioid addiction
09/18/2014US20140271754 Polymeric materials providing improved infrared emissivity
09/18/2014US20140271735 Use of calcitonin in osteoarthritis
09/18/2014US20140271732 Wound healing using topical systems and methods
09/18/2014US20140271731 Cardiovascular disease treatment and prevention
09/18/2014US20140271730 Immune modulation using peptides and other compositions
09/18/2014US20140271722 Allergen dosage form
09/18/2014US20140271717 Devices containing a chemical denervation agent and methods for treating chronic back pain using chemical denervation
09/18/2014US20140271716 Intra-testicular Injection of Immunogens
09/18/2014US20140271713 Method for keeping a food and mouth disease vaccine available for emergency vaccination
09/18/2014US20140271695 Immunogenic lhrh compositions and methods relating thereto
09/18/2014US20140271637 Methods of administering anti-tnfalpha antibodies
09/18/2014US20140271636 Formulation of an antibody and use thereof
09/18/2014US20140271613 Surgical Compositions
09/18/2014US20140271612 Treatment Method and Product for Uterine Fibroids using Purified Collagenase
09/18/2014US20140271597 Treatment of ophthalmic conditions
09/18/2014US20140271576 Self-Gelling Alginate Systems and Uses Thereof
09/18/2014US20140271572 Adipose tissue mesenchymal stem cells and methods of use to treat or inhibit uterine disorders
09/18/2014US20140271527 Subcutaneous delivery of polymer conjugates of therapeutic agents
09/18/2014US20140271501 Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
09/18/2014US20140271494 Wax Foamable Vehicle And Pharmaceutical Compositions Thereof
09/18/2014US20140271493 (Trimethoxyphenylamino) Pyrimidinyl Formulations
09/18/2014US20140271492 Manufacturing Process for Effervescent Dosage Forms
09/18/2014US20140271489 Polymeric depots for localization of agent to biological sites
09/18/2014US20140271487 Prussian blue-inspired constructs for multimodal imaging and therapy
09/18/2014US20140271473 Encapsulated metal ion nanoclusters
09/18/2014US20140271472 Methods and devices for lung volume reduction with extracellular matrix material
09/18/2014US20140271471 Thermo-sensitive bone growth compositions
09/18/2014US20140262868 Ceftolozane-tazobactam pharmaceutical compositions
09/18/2014US20140261499 Electronic cigarette
09/18/2014US20140260098 Method and system for producing high purity vancomycin hydrochloride
09/18/2014DE102006028783B4 Poröser Siliziumkörper mit schichtartigem Aufbau, Verfahren zu dessen Herstellung sowie Verwendung desselben Of the same porous silicon body with a layer-structure, processes for its preparation and use
09/17/2014EP2778167A1 Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt
09/17/2014EP2777805A2 Emulsifying preparation
09/17/2014EP2777802A1 Multi-Compartment Dosage Form Articles
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 2991